U.S. pharmaceutical stocks rallied collectively on Tuesday. Eli Lilly and Johnson & Johnson surged over 4% and 3% respectively, both hitting all-time highs. Crinetics Pharmaceuticals Inc. skyrocketed nearly 100%, while Gilead Sciences rose 4.5%. Pfizer and AbbVie gained over 2%, with Merck and Novo Nordisk climbing nearly 2%.
Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals Inc. in Deal Valued at Roughly $10 Billion; Blockbuster M&A Lifts Entire Sector Sentiment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments